Health Data Research UK Selects MMS as Partner for International COVID-19 Data Alliance


MMS Holdings Inc. has been selected by Health Data Research UK as a partner to support the International COVID-19 Data Alliance (ICODA) initiative. MMS was selected from a pool of the world’s clinical research organizations to provide data engineering services to support a globally coordinated, health data-led research response to tackle the COVID-19 pandemic.

ICODA is an open and inclusive global collaboration of life science, philanthropic and research organizations that have come together to harness the power of health data to respond to the COVID-19 pandemic. Uniting data from a broad set of contributors will enable discoveries that will help treat and prevent COVID-19 and coordinate effective data responses to health challenges of the future.

During the pilot phase of the project, MMS will provide flexible service levels based on the capability of each contributor to transform their data to ICODA standards. The MMS biometrics and data science team will provide simple guidance to the full range of data services and data mapping as needed.

After the pilot completes, MMS data scientists will use learnings to develop tools to further enable contributors such as open-source code and training that academic researchers can use to transform their own data. Additionally, later phases of the engagement may include data mapping and incorporation of real-world health data.

Learn more about ICODA here

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.